Counterpoint Mutual Funds’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,625
Closed -$158K 330
2022
Q4
$158K Buy
+15,625
New +$158K 0.17% 42